Managers / Q4 2020 · view latest →
Euclidean Technologies Management, LLC
CIK 0001597864 · 701 5TH AVE, SUITE 4200, SEATTLE, WA, 98104 · 206-839-8586
Summary
Euclidean Technologies Management, LLC reported $95M in U.S.-listed holdings across 55 positions for Q4 2020.
Its largest position, MED, represents 3.5% of the portfolio.
Compared with Q3 2020, the fund opened 1 new position and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $95M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| KIMBALL INTL INC | NEW | +11.4K | 11.4K | +$136,000 | $136,000 |
| TGTREDEGAR CORP | ADDED | +71.0K | 119.7K | +$1M | $2M |
| BIIBBIOGEN INC | SOLD OUT | −7.9K | 0 | −$2M | $0 |
| NUENUCOR CORP | SOLD OUT | −27.4K | 0 | −$1M | $0 |
| IHRTIHEARTMEDIA INC | SOLD OUT | −107.0K | 0 | −$869,000 | $0 |
| GMEGAMESTOP CORP NEW | SOLD OUT | −50.8K | 0 | −$518,000 | $0 |
| NXQUANEX BUILDING PRODUCTS COR | ADDED | +34.2K | 84.3K | +$946,000 | $2M |
| SGCSUPERIOR GROUP OF CO INC | ADDED | +22.7K | 56.8K | +$528,000 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2023 | $109M | 75 | Apr 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $105M | 71 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $89M | 67 | Oct 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $97M | 73 | Jul 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $108M | 83 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $120M | 90 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $115M | 82 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $125M | 95 | Aug 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $115M | 69 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $95M | 55 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $79M | 58 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $71M | 56 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $61M | 56 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $96M | 59 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $107M | 66 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $106M | 67 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $108M | 67 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.